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Major depressive disorder (MDD) is a leading contributor to global disease burden. Recent 
studies have shown that genetic factors play significant roles in the susceptibility to this 
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condition; however, the underlying genetic basis currently remains largely unknown. Short 
tandem repeat (STR) has been proposed as an explanatory factor in the “missing heritability” 
of complex diseases or traits.  
Methods:  
We investigated STR variations from 15 MDD patients and 10 ethnically matched healthy 
controls based on their deep whole-genome sequencing (WGS) data. The lobSTR software 
was used to computationally determine STRs.  
Results:  
The results of the Mexican-American sample showed that STRs are significantly richer in 
healthy controls than in MDD cases on each of the 23 chromosomes (all false discovery rates, 
FDR P-values < 0.0062); while for the Australian of European-ancestry sample, there was no 
statistically significant STRs difference between MDD cases and controls. 
Limitations:  
High quality WGS costs limited obtaining larger datasets.  
Conclusions:  
This preliminary work is the first study that STR variations are applied to investigate MDD 
based on WGS data. The results on Mexican-American population may imply that within the 
same ancestry, targeted sequencing on a specific chromosome or region of genome would be 
sufficient for examining the relationship between STR and MDD. Further studies should 
examine larger sequencing datasets on other ethnic groups. 
Abbreviations:  
MDD, major depressive disorder; STR, short tandem repeat; WGS, whole-genome 
sequencing; GWAS, genome-wide association studies; FDR, false discovery rate; VCF, 
variant call format; MA, Mexican-American  
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1. Introduction  
        Major depressive disorder (MDD) is a common brain disorder that causes a persistent 
feeling of sadness and loss of pleasure in rewarding or enjoyable activities. MDD produces 
serious morbidity and mortality, and leads to high rates of completed suicide (Kessler et al., 
2005; Lopez and Murray, 1998; Wong and Licinio, 2001). Genetic components play 
significant roles in the development of MDD, as indicated by family, twin, and adoption 
studies (Lohoff, 2010; Sullivan et al., 2000). Although the heritability of MDD was estimated 
to range between 40-70% (Lesch, 2004), the identification of genetic factors has been proved 
to be challenging (Flint and Kendler, 2014). Genome-wide association studies (GWAS) have 
recently made huge advances (Amin et al., 2016; CONVERGE Consortium, 2015; Hyde et 
al., 2016; Peterson et al., 2017); however, the underlying biological causes of major 
depression remains largely unknown, and much research still needs to be carried out to fully 
elucidate the genetic predisposition to this serious condition (Sullivan et al., 2012; Wong et 
al., 2017; Yu et al., 2017b, 2017c).  
        Many studies have investigated genetic factors of complex diseases or traits to try to 
explain their “missing heritability” (Manolio et al., 2009; Eichler et al., 2010; Lee et al., 2011; 
Zuk et al., 2012). For example, genetic effects are not only due to common genetic variants 
such as single-nucleotide polymorphisms examined in GWAS, but also owing to low-
frequency/rare variants, copy-number variations, and other kinds of genetic mutations (Wray 
et al., 2014; Yu et al., 2017d). Short tandem repeat (STR) variation has been recently 
proposed as an explanatory factor on the heritability of complex diseases or traits in humans 
and model organisms (Hannan, 2010; Press et al., 2014; Fungtammasan et al., 2015; Gymrek, 
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2017). STRs, also known as microsatellites, refer to a class of genetic variations with 
continuous repetitive patterns of 2-6 nucleotides such as ACACACACAC or 
TCGGTCGGTCGG. These simple pattern repeats usually mutate much more quickly than 
other variations and have been linked to some neurological conditions such as Huntington’s 
disease and motor neurone disease (Mirkin, 2007). For example, Huntington’s disease is 
triggered by the expansion of a large number of trinucleotide “CAG” repeats (Snell et al., 
1993). Furthermore, STR variations can affect neuronal differentiation, brain development 
and even behavioural evolution (Fondon et al., 2008); thus, we believe that STR variations 
could also explain some of major depression heritability.  
        The rapid development of whole-genome sequencing (WGS) is allowing researchers to 
develop novel approaches for personalized medicine studies (Hamburg and Collins, 2010). 
WGS can identify all genetic variations within each person, and as WGS costs continue to 
drop further, scientists may have the opportunity to investigate the significance of these 
variations (Belkadi et al., 2015). The aim of the current study is, based on WGS data, to 
identify STRs in MDD subjects and healthy controls, and examine if they are significantly 
different in the two groups. To our knowledge, there has been no study to investigate STRs 
with major depression in literature so far.  
 
2. Materials and Methods 
2. 1 The Mexican-American sample  
        We have recently studied a Mexican-American cohort including 203 MDD patients and 
196 healthy controls, aged 19-65 years (Wong et al., 2017, Yu et al., 2017a). All participants 
lived in Los Angeles, USA and had three or more grandparents born in Mexico. MDD cases 
were diagnosed using the SCID [Structured Clinical Interview for DSM-IV (Diagnostic and 
Statistical Manual IV edition)]. Patients met diagnostic criteria for current, unipolar major 
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depressive episode, participated in a pharmacogenetic study of antidepressant treatment and 
had an initial HAM-D21 (21-Item Hamilton Depression Rating Scale) score of 18 or greater 
with item number 1 (depressed mood) rated 2 or greater. MDD was defined as 5 out of 9 
criteria in the SCID. Controls were in general good health and were not screened for medical 
or psychiatric illnesses; they were age- and gender-matched Mexican-American individuals 
recruited from the same community in Los Angeles. All participants have submitted written 
informed consent. The study was registered in ClinicalTrials.gov (NCT00265291), and 
approved by the institutional review boards of the University of California Los Angeles and 
University of Miami, USA, and by the human research ethics committees of the Australian 
National University and Bellbery Ltd, Australia.  
        For the current study, we acquired complete WGS data for a group of 15 subjects from 
the cohort, 10 MDD patients and 5 controls. Considering confounding factors, we controlled 
blood relationship, gender and age for those 15 selected Mexican-American participants. We 
have confirmed that there were no blood relatives between those 15 Mexican-American 
subjects. All those subjects were female, and the MDD case group had an average age of 38.8 
years with standard deviation 8.15 and the control group had an average age of 39.6 years 
with standard deviation 7.36. Thus, the two groups have basically the same age distribution 
(see Table S1). WGS was performed using Illumina HiSeq 2000 (BGI-Shenzhen, Shenzhen, 
Guangdong, China) with a depth of 30 X or greater.   
2.2 The Australian of European-ancestry sample 
        As a population comparison, we also included complete WGS data from a group of 10 
Australian subjects of European-ancestry. Ten subjects, including 5 MDD cases and 5 healthy 
controls, were recruited under the protocol of the Cognitive Function and Mood Study 
(CoFaM-Study) conducted by the Discipline of Psychiatry, University of Adelaide, South 
Australia, Australia, and have submitted written informed consent (Baune and Air, 2016). 
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The CoFaM-Study was approved by human research ethics committees at the University of 
Adelaide, South Australia, Australia. Mini International Neuropsychiatric Interview (MINI) 
was used for diagnosing both the MDD patients and the healthy controls. The HAM-D21 
scores were also assessed for those subjects. WGS was performed using Illumina HiSeq X 
(Garvan Institute, Sydney, New South Wales, Australia) with a depth of 40 X or greater.  
        The descriptive statistics of gender, age and HAM-D21 scores for the 15 Mexican-
American participants and the 10 Australian participants were previously presented (Yu et al., 
2007e). Here we also included them in Table S1. The Australian sample included both 
remitted depressed and acutely depressed subjects. The remitted depressed ones had by 
definition a lower depression severity compared to acutely depressed subjects. Therefore, the 
HAM-D scores for the Australian sample may be lower on average than the Mexican-
American sample. 
2.3 STR calling based on WGS 
        We applied the lobSTR software (lobstr.teamerlich.org) to call STRs using WGS of each 
subject (Gymrek et al., 2012). LobSTR utilizes theories from statistical learning and signal 
processing to avoid gapped alignments and to address specific noise patterns in STR profiling. 
The reliability and speed of lobSTR surpass the performance of existing mainstream 
programs for STR calling (Gymrek, 2017). Briefly, we firstly aligned cleaned paired-end read 
files of each subject to STR-containing regions of the hg19 reference genome in lobSTR 
package. Then we obtained a BAM (a binary version document) file with reads aligning to 
STRs. Similarly, as in the routine WGS analysis, we needed to sort and index the BAM file 
using SAMtools software (Li et al., 2009). After that, we run the “allelotype” commended in 
lobSTR to generate the output VCF (variant call format) files containing all STR calling 
information. The next step was to filter VCF files by testing if STR passes or not based on a 
number of metric parameters. We used the recommended filtering parameters on the lobSTR 
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webpage such as average coverage or call rate. Finally, we extracted all passed STR 
information from the VCF files for current analysis (See Supplementary Material for WGS 
and STR analysis details). All STR calling jobs based on WGS were performed using high-
performance computing services in eResearch South Australia (www.ersa.edu.au).  
2.4 Statistical analysis 
        We used independent two-tailed Student’s t-test to examine differences of STR numbers 
between two groups. We tested 23 chromosomes, and multiple comparisons were corrected 
using the false discovery rate (FDR) method (Benjamini and Hochberg, 1995) with 
significance level set at < 0.05. All statistical calculations and graphs were performed using 
the R software (www.r-project.org).   
 
3. Results 
        Firstly, we investigated the total STR numbers for 25 subjects in two groups (15 MDD 
cases and 10 healthy controls). One STR refers to a continuous repetitive sequence of 2-6 
nucleotides such as CATCATCATCAT. The total STR numbers were 993,817.2 + 81,111.45 
(mean + standard deviation) in the MDD group, and 1,017,073.0 + 102,399.22 in the control 
group. There was no significant difference between the two groups (P value = 0.53, t-statistic 
= -0.63). Taking into account population differences, we examined the total STR numbers 
respectively for Mexican-American sample (10 MDD cases and 5 controls) and Australian 
sample (5 MDD cases and 5 controls). Figure 1 illustrates these comparisons. In the Mexican-
American sample, a large significant difference was found between MDD cases and controls 
(P value < 0.0001, t-statistic = -6.32); controls had significantly more STR numbers than 
MDD individuals. However, there was no significant difference between MDD cases and 
controls in the Australian sample (P value = 0.51, t-statistic = 0.69).  
8 
 
        Furthermore, we examined STR number distributions on 23 chromosomes (we 
considered chromosome X as the 23th one since most subjects were female) for the Mexican-
American and Australian samples. As shown in Figure 2, we calculated the arithmetic means 
and standard deviations for four subject groups (Australian control; Australian depressed; 
Mexican-American control; Mexican-American depressed) for each of the 23 chromosomes. 
The two populations had different distribution curves as indicated by STR numbers on the Y-
axis, but within a population, the curve shapes were similar for cases and controls. Results for 
these findings were summarised in Tables 1 and 2. For the Mexican-American sample, the 
average STR number in control group was significantly larger than in MDD group in each of 
the 23 chromosomes (all 23 FDR P values < 0.0062); while for the Australian sample, 
although we see the opposite situation (see t-statistics in Tables 1 and 2), there is no any 
significant difference for the STR numbers on all 23 chromosomes.    
 
4. Discussion 
        STR variation, as a powerful genetic marker, has been instrumental in a wide range of 
applications including forensics (Butler, 2006, 2007), molecular anthropology (Zhivotovsky 
et al., 2004; Chapuis and Estoup, 2007) and cancer genetics (Parson et al., 2005). To the best 
of our knowledge, our study is the first one in which STRs were applied to depression 
research. Our results suggest that, within the Mexican-American population, STRs are 
significantly richer in healthy controls than in MDD cases on each of 23 chromosomes. But 
for Australian of European-ancestry population, we could not conclude any significant results 
based on our data. This could be due to the fact that the size of our Australian sample is very 
small, which may have led to low statistical power. This result could also be explained by 
population genetics of STRs as different ethnic groups have different allele frequency 
distributions on STR regions (Gill and Evett, 1995). Moreover, we have contributed the 
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Mexican-American sample to the International Haplotype Map (HapMap) Project from the 
same community as subjects in this study. Mexican-Americans from that Los Angeles 
community have been proved to possess median ancestry proportions that are 49% European, 
45% Indigenous American, and 5% African (Johnson et al., 2011). According to population 
clustering results based on 100 most variable STR loci (Willems, et al., 2014), it would be 
expected that individuals with African ancestry, such as Mexican-Americans, have very 
different genetic structures from those of European ancestry. Another possible reason that 
Australian MDD cases and controls have no significant differences on STR numbers could be 
due to the confounding factor sex. As shown in Table S1, for Australian sample, there are one 
male and four females in MDD group but three males and two females in control group. This 
difference in sex composition could impact the STR numbers observed (Butler and Li, 2014). 
        The significant difference on each of 23 chromosomes could be a signal that targeted 
sequencing on a specific chromosome or region of genome would be sufficient for examining 
the relationship between STRs and MDD. For example, in the Mexican-American cohort 
there is a very significant difference between depression cases and controls on chromosome 
16 (P-value = 83.5119 10 , FDR = 78.0774 10 ). A recent study on chromosomal change 
also pointed out that “16p11.2-p12.2 duplication syndrome” is a recurrent genomic disorder 
with a variable phenotype including developmental delay, dysmorphic features, mild to 
severe intellectual disability, autism and obsessive or stereotyped behaviours (Barber et al., 
2013). Those phenotypic characteristics are related to brain function and may have some 
links to MDD. Therefore, checking differences on STR numbers could provide a valuable 
assisting tool for investigating major depression clinically. Sequencing on a specific region of 
genome acting in concert with clinical symptoms has the potential to be translated to clinical 
practice and could include the ability to diagnose depressed patients. Future studies on larger 
genetic and clinical data will be needed to test the robustness of this potential approach.    
10 
        The main limitation of current study is the small sample size. Although next-generation 
sequencing techniques will dramatically improve our capability to detect all types of genomic 
variations, high-quality deep (> 30X) genome sequencing expenses are currently still a 
concern that limits obtaining larger WGS datasets. High requirements of computational 
resources are also indispensable for big data analysis (Liu et al., 2017). Thus, future research 
should examine larger WGS data and additional replication samples from other ethnic groups. 
Supplementary Material 
        Supplementary material to this article can be found online at the electronic version of 
this journal. It includes Table S1 and supplementary text about details of WGS and STR 
Analysis.  
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Figure 1. Total STR numbers of depressed and healthy control groups for two populations 
(Australian of European-ancestry and Mexican-American). Error bars represent standard 
deviation.   
Figure 2. STR number distributions on 23 chromosomes for depressed and healthy control 




Table 1. Results for STR numbers on 23 chromosomes between European-ancestry 
Australian MDD (AUD) and control (AUC). FDR, false discovery rate.  
Chromosome 
t-test for STR between groups AUD and AUC 
t-statistic P-value FDR 
1  0.5873 0.5732 0.7768 
2  0.6631 0.5259 0.7768 
3  0.6968 0.5057 0.7768 
4  0.7675 0.4648 0.7768 
5  0.7110 0.4973 0.7768 
6  0.7026 0.5023 0.7768 
7  0.6449 0.5370 0.7768 
8  0.6764 0.5179 0.7768 
9  0.5902 0.5713 0.7768 
10  0.6194 0.5529 0.7768 
11  0.6593 0.5282 0.7768 
12  0.6404 0.5398 0.7768 
13  0.7296 0.4865 0.7768 
14  0.5955 0.5680 0.7768 
15  0.5220 0.6158 0.7850 
16  0.3960 0.7024 0.7850 
17  0.3759 0.7168 0.7850 
18  0.6878 0.5110 0.7768 
19  0.3126 0.7626 0.7973 
20  0.4567 0.6600 0.7850 
21  0.5858 0.5742 0.7768 
22  0.2024 0.8447 0.8447 
X  1.2550 0.2449 0.7768 
 
Table 2. Results for STR on 23 chromosomes between Mexican-American MDD (MAD) and 
control (MAC). FDR, false discovery rate.  
Chromosome 
t-test for STR between groups MAD and MAC 
t-statistic P-value FDR 
1 -6.7844 1.2927E-05 2.7524E-05 
2 -4.9732 2.5474E-04 3.6619E-04 
3 -4.6043 4.9382E-04 6.3100E-04 
4 -3.2585 6.2254E-03 6.2254E-03 
5 -4.3015 8.6085E-04 1.0421E-03 
6 -4.6737 4.3542E-04 5.8910E-04 
7 -6.8970 1.0902E-05 2.7524E-05 
8 -5.4899 1.0391E-04 1.5933E-04 
9 -7.3143 5.8806E-06 2.2542E-05 
10 -6.1352 3.5716E-05 5.8677E-05 
11 -7.2077 6.8701E-06 2.2573E-05 
12 -6.2034 3.2014E-05 5.6640E-05 
13 -3.6592 2.8862E-03 3.0174E-03 
14 -6.2810 2.8288E-05 5.4220E-05 
15 -6.9424 1.0182E-05 2.7524E-05 
16 -11.4900 3.5119E-08 8.0774E-07 
17 -9.1716 4.8600E-07 2.7945E-06 
18 -4.0940 1.2674E-03 1.4575E-03 
18 
 
19 -9.6813 2.6165E-07 2.0059E-06 
20 -8.0636 2.0503E-06 9.4315E-06 
21 -6.7725 1.3164E-05 2.7524E-05 
22 -10.4899 1.0301E-07 1.1846E-06 
X -4.0312 1.4259E-03 1.5617E-03 
 
Highlights 
 It is the first study that STRs detected by WGS data were used to investigate MDD.  
 WGS can detect all private genetic variations including STR within an individual. 
 We analysed WGS data of 25 human subjects including 15 MDDs and 10 controls.  
 There were significantly different STR numbers between MDD cases and controls.   
 The significant difference was found on each chromosome for MA population.  
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